Medlive Technology Co Ltd
HKEX:2192

Watchlist Manager
Medlive Technology Co Ltd Logo
Medlive Technology Co Ltd
HKEX:2192
Watchlist
Price: 9.76 HKD -1.71%
Market Cap: 7.2B HKD
Have any thoughts about
Medlive Technology Co Ltd?
Write Note

Medlive Technology Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medlive Technology Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Medlive Technology Co Ltd
HKEX:2192
Additional Paid In Capital
ÂĄ3.9B
CAGR 3-Years
629%
CAGR 5-Years
229%
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Additional Paid In Capital
ÂĄ12B
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Additional Paid In Capital
ÂĄ392.5m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
6%
B-SOFT Co Ltd
SZSE:300451
Additional Paid In Capital
ÂĄ1.6B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Heren Health Co Ltd
SZSE:300550
Additional Paid In Capital
ÂĄ610.8m
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Additional Paid In Capital
ÂĄ957.8m
CAGR 3-Years
21%
CAGR 5-Years
8%
CAGR 10-Years
16%
No Stocks Found

Medlive Technology Co Ltd
Glance View

Market Cap
7.1B HKD
Industry
Health Care

Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.

Intrinsic Value
6.74 HKD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Medlive Technology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
3.9B CNY

Based on the financial report for Dec 31, 2023, Medlive Technology Co Ltd's Additional Paid In Capital amounts to 3.9B CNY.

What is Medlive Technology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
229%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Medlive Technology Co Ltd have been 629% over the past three years , 229% over the past five years .

Back to Top